Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 700 | $214.60 | $150,220.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 11 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.60 to $214.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 2,800 | $213.64 | $598,192.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 10 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.48 to $214.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 634 | $212.20 | $134,534.80 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 9 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.01 to $212.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 16,344 | $14.43 | $235,843.92 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 8 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 200 | $217.45 | $43,490.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 7 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.42 to $217.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 400 | $216.24 | $86,496.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 6 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.15 to $216.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 1,400 | $214.46 | $300,244.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 5 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.125 to $214.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 1,200 | $213.71 | $256,452.00 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 4 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.10 to $214.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 2,555 | $212.54 | $543,039.70 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 3 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.01 to $212.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
SaleCommon Shares | 2,911 | $211.44 | $615,501.84 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 2 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,755 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.01 to $212.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 23:07 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 8,666 | $12.57 | $108,931.62 |
DisclosureSEC source: 0001209191-21-004458 · doc4.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2021 Filed Mar 12, 2021 22:37 UTC Amendment |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 16,334 | $14.43 | $235,699.62 |
DisclosureSEC source: 0001209191-21-020248 · doc4a.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amended Form 4 is being filed to correct the number of shares acquired on January 15, 2021. Read SEC document |
| January 02, 2021 Filed Jan 4, 2021 21:12 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingCommon Shares | 9,392 | $153.11 | $1,438,009.12 |
DisclosureSEC source: 0001209191-21-000256 · doc4.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,608 F1 · kind: On January 2, 2019, the reporting person was granted 20,000 restricted stock units. The restricted stock units vested in full on January 2, 2021. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 21:02 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,800 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-20-065501 · doc4.xml · derivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,983 Underlying: Common Shares · 13,800 shares Expires 2025-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vest in equal 36 monthly installments thereafter. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 21:02 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 13,800 | $1.81 | $24,978.00 |
DisclosureSEC source: 0001209191-20-065501 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
Exercise / conversionStock Option (right to buy) · Derivative | 23,551 | $0.00 Strike: $16.90 | $0.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · derivative · entry 11 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,449 Underlying: Common Shares · 23,551 shares Expires 2027-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: This option was granted on August 1, 2017 with respect to 260,000 Common Shares of which 25% vested on 8/1/2018 and the remaining 75% vest in 36 equal monthly installments on the final day of each succeeding calendar month. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 2,951 | $150.61 | $444,450.11 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 10 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,964 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.44 to $151.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 5,000 | $149.73 | $748,650.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 9 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,915 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.20 to $150.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 8,400 | $148.38 | $1,246,392.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 8 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,915 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.19 to $149.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 1,400 | $147.05 | $205,870.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 7 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,315 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 to $147.125, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 500 | $152.41 | $76,205.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 6 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,715 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.04 to $152.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 1,100 | $151.58 | $166,738.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 5 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,215 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 1,600 | $150.16 | $240,256.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 4 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,315 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.755 to $150.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 900 | $149.18 | $134,262.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 3 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,915 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.69 to $149.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
SaleCommon Shares | 1,700 | $148.11 | $251,787.00 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 2 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,815 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.44 to $148.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:55 UTC |
Ho Tony WExecutive VP, Head of R&D
|
Exercise / conversionCommon Shares | 23,551 | $16.90 | $398,011.90 |
DisclosureSEC source: 0001209191-20-064857 · doc4.xml · nonDerivative · entry 1 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 217 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 931 | $151.05 | $140,625.13 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 10 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 339,834 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F3 · shares: These securities are held of record by VVM LLC, for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $150.79 to $151.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 969 | $151.05 | $146,364.93 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 9 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F8 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $150.79 to $151.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 958 | $150.14 | $143,837.19 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 8 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 340,765 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F3 · shares: These securities are held of record by VVM LLC, for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $149.77 to $150.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 995 | $150.14 | $149,392.48 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 7 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F7 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $149.77 to $150.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,009 | $149.12 | $299,586.50 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 6 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 341,723 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F3 · shares: These securities are held of record by VVM LLC, for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $148.72 to $149.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,091 | $149.12 | $311,814.52 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 5 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,964 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F6 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $148.72 to $149.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,576 | $148.28 | $381,972.11 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 4 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 343,732 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F3 · shares: These securities are held of record by VVM LLC, for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $147.67 to $148.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,679 | $148.28 | $397,245.07 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 3 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,055 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F5 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $147.67 to $148.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 878 | $147.00 | $129,067.76 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 2 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 346,308 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F3 · shares: These securities are held of record by VVM LLC, for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $146.67 to $147.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 16, 2020 Filed Dec 19, 2020 00:12 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 914 | $147.00 | $134,359.83 |
DisclosureSEC source: 0000899243-20-034537 · doc4.xml · nonDerivative · entry 1 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,734 F1 · kind: The sale of these shares was effected pursuant to Rule 10b5-1 trading plans adopted by each of the Reporting Person and Versant Venture Management, LLC ("VVM LLC"), respectively. F2 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $146.67 to $147.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 00:14 UTC Amendment |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 15,900 | $144.85 | $2,303,154.75 |
DisclosureSEC source: 0000899243-20-034324 · doc4a.xml · nonDerivative · entry 5 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,648 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $144.04 to $144.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 00:14 UTC Amendment |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,223 | $143.26 | $318,462.31 |
DisclosureSEC source: 0000899243-20-034324 · doc4a.xml · nonDerivative · entry 4 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,548 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $143.00 to $143.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 00:14 UTC Amendment |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 5,958 | $142.42 | $848,562.19 |
DisclosureSEC source: 0000899243-20-034324 · doc4a.xml · nonDerivative · entry 3 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,771 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $142.00 to $142.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 00:14 UTC Amendment |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 6,648 | $141.53 | $940,923.35 |
DisclosureSEC source: 0000899243-20-034324 · doc4a.xml · nonDerivative · entry 2 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,729 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $141.10 to $141.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 00:14 UTC Amendment |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,271 | $140.62 | $319,345.29 |
DisclosureSEC source: 0000899243-20-034324 · doc4a.xml · nonDerivative · entry 1 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,377 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $140.20 to $140.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · derivative · entry 7 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,783 Underlying: Common Shares · 20,000 shares Expires 2025-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vest in equal 36 monthly installments thereafter. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 600 | $144.97 | $86,982.00 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 6 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,189 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.95 to $145.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 2,100 | $143.71 | $301,791.00 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 5 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,789 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.63 to $144.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 6,766 | $142.75 | $965,846.50 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,889 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.61.00 to $143.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 5,034 | $141.98 | $714,727.32 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,655 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.54 to $142.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 5,500 | $141.17 | $776,435.00 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,689 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.53 to $141.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 21:05 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 20,000 | $1.81 | $36,200.00 |
DisclosureSEC source: 0001209191-20-062919 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2020 Filed Dec 15, 2020 00:11 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 15,900 | $144.85 | $2,303,154.75 |
DisclosureSEC source: 0000899243-20-033783 · doc4.xml · nonDerivative · entry 5 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 314,186 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $144.04 to $144.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (8) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 10, 2020 Filed Dec 15, 2020 00:11 UTC |
Bolzon Bradley J PhDDirector
|
SaleCommon Shares | 2,223 | $143.26 | $318,462.31 |
DisclosureSEC source: 0000899243-20-033783 · doc4.xml · nonDerivative · entry 4 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 330,086 F1 · kind: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: These securities are held of record by Versant Venture Management, LLC ("VVM LLC"), for the benefit of the Reporting Person, pursuant to an agreement between VVM LLC and the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $143.00 to $143.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (7) to this Form 4. F4 · ownership.nature: These securities are held of record by VVM LLC. The Reporting Person is a managing member of VVM LLC and the Reporting Person may be deemed to indirectly beneficially own the securities through his interest in VVM LLC. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.